Open Accessibility Menu
Hide

Monoclonal Antibody Therapy

If you test positive for COVID-19 or know you were exposed to COVID-19 and are at high risk for complications, you may benefit from the monoclonal antibody therapy REGEN-COV™.

Complete Screening Questionnaire

REGEN-COV™ is used for the treatment of patients with mild to moderate COVID-19 who are at increased risk for progressing to severe disease and/or requiring hospitalization. It is also used to prevent COVID-19 in patients who have been exposed to the virus and are at increased risk of progressing to severe disease and/or requiring hospitalization.

REGEN-COV™ is not available for patients who require oxygen to treat their COVID-19 symptoms.

If any of the criteria below apply to you, you may be eligible for REGEN-COV™.

  • Older age (Ex: age ≥65 years of age)
  • Obesity or being overweight
  • Pregnancy
  • Chronic kidney disease
  • Diabetes
  • Immunosuppressive disease or immunosuppressive treatment (like daily prednisone)
  • Heart disease (including congenital heart disease)
  • Hypertension
  • Lung diseases (Ex: chronic obstructive pulmonary disease, asthma [moderate-to-severe], interstitial lung disease, cystic fibrosis, or pulmonary hypertension)
  • Sickle cell disease
  • Neurodevelopmental problems (Ex: cerebral palsy) or other conditions that confer medical complexity (Ex: genetic or metabolic syndromes, or severe congenital anomalies)
  • Having a medical-related technological dependence (Ex: tracheostomy, gastrostomy, or positive pressure ventilation not related to COVID-19)

The FDA has authorized REGEN-COV™ for emergency use. It consists of two investigational medicines, casirivimab and imdevimab, given together either as an infusion or as injections under the skin. At St. Claire HealthCare, it is given as injections and treatment usually takes about two hours from start to finish. Appointments are required, but referrals are not necessary.

SCH provides REGEN-COV™ to eligible patients at no cost.

Find out if Regen-COV™ is right for you. Complete our screening questionnaire.